Cypress Investors Resist $163M Ramius Takeover Bid
By Erin Marie Daly ( September 21, 2010, 5:37 PM EDT) -- Cypress Bioscience Inc. shareholders have accused the company's board of directors of breaching its fiduciary duties by failing to adequately consider whether a $163 million hostile takeover bid by a unit of Ramius LLC maximizes shareholder value....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.